Silver Book Fact

Drastic reduction of morbidity from vaccine-preventable disease in 20th century

In the 20th century, vaccines have reduced the morbidity from vaccine-preventable diseases by as much as 89–100%.

Pharmaceutical Research and Manufacturers of America. Vaccine Fact Book 2013. Washington, D.C.: PhRMA; 2013. http://www.phrma.org/sites/default/files/pdf/PhRMA_Vaccine_FactBook_2013.pdf

Reference

Title
Vaccine Fact Book 2013
Publisher
PhRMA
Publication Date
2013
Authors
Pharmaceutical Research and Manufacturers of America
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Shingles vaccine reduces incidence by >50%
    Use of a live attenuated VZV (varicella-zoster vaccine) in a randomized trial reduced the incidence of shingles by 51.3%.  
  • Only a 20% reduction in drug-resistant infections would save $3.2 – $5.2 billion each year
    A 20% reduction in drug-resistant infections would save between 5.7 and 11.3 million additional hospital days and between $3.2 and $5.2 billion in healthcare costs, each year.  
  • Potential value of pneumonia vaccine
    Use of PCV13 (13-valent pneumococcal conjugate vaccine) in older adults is estimated to have the potential to reduce total healthcare costs by $3.5 billion and total societal costs by $7.4…  
  • Over 6 years, flu vaccine prevented >110,000 hospitalizations and 5.8 million medical visits
    Over a 6-year period (2005 – 2011), the influenza vaccine prevented more than 110,000 hospitalizations and 5.8 million medical visits.  
  • Cost of pneumonia vaccine
    Addition of PCV13 (13-valent pneumococcal conjugate vaccine) to previously recommended pneumococcal polysaccharide vaccine for immunocompromised adults cost $70,937 per quality adjusted life year compared to no vaccine.